Ask Warren

Jeil Pharmaceutical

271980 · KOSPI · ₩271980 · 제일약품

₩8,600▼ ₩230 (2.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩147B₩130B₩132B₩135B₩138B₩163B₩187B₩174B
Cost of sales₩87B₩77B₩79B₩80B₩84B₩111B₩135B₩136B
Gross profit₩59B₩53B₩53B₩55B₩53B₩52B₩52B₩38B
Operating income−₩7B₩418M₩534M₩9.8B₩4.7B₩5.7B₩2.4B−₩4.1B
Net income−₩6.7B₩3.2B₩9.5B₩16B₩3B₩3.6B₩6.2B−₩5.5B
Net income to shareholders−₩8B−₩310M₩7.4B₩10B₩3.1B₩2.6B₩3.6B−₩4.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩526B₩515B₩511B₩502B₩486B₩506B₩526B₩493B
Current assets₩330B₩323B₩312B₩312B₩304B₩324B₩343B₩324B
Cash and equivalents₩59B₩53B₩49B₩52B₩49B₩47B₩53B₩34B
Total liabilities₩273B₩258B₩260B₩258B₩259B₩281B₩306B₩309B
Current liabilities₩248B₩240B₩242B₩241B₩243B₩266B₩292B₩296B
Borrowings₩110B₩95B₩90B₩90B₩90B₩76B₩71B₩71B
Total equity₩253B₩257B₩251B₩244B₩227B₩225B₩219B₩184B
Shareholders' equity₩206B₩213B₩211B₩205B₩194B₩193B₩188B₩169B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩9.5B−₩7.4B₩532M₩13B−₩8.5B−₩11B₩1B₩2.5B
Capital spending₩6.2B₩1.7B₩2.2B₩2.6B₩2.8B₩468M₩1.7B₩1B
Free cash flow−₩16B−₩9.1B−₩1.7B₩11B−₩11B−₩11B−₩652M₩1.5B
Dividends paid—₩0₩0₩0₩0₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: Jeil Pharmaceutical / 제일약품 / 271980 / KRX:271980

Source: KRX statistical information